http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View More Recent Stories
-
agilon health Reports First Quarter 2022 Results
-
agilon health and United Physicians form Long-term Partnership to Provide a Value-Based Care Model for Medicare Advantage in Southeast Michigan
-
agilon health to Participate in BofA Securities 2022 Healthcare Conference
-
agilon health Sets Date to Report First Quarter 2022 Financial Results
-
Agilon Health Inc. (AGL) Partners with MaineHealth to Accelerate Primary Care Delivery for Patients
-
agilon health Partners with MaineHealth, Northern New England’s Largest Integrated Health System, to Accelerate Primary Care Delivery for Patients
-
agilon health Reports Fourth Quarter and Fiscal Year 2021 Results
-
agilon health Appoints Two New Executives to Leadership Team
-
agilon health to Host Investor Day on March 11
-
agilon health to Participate in 40th Annual J.P. Morgan Healthcare Conference
-
agilon health to Participate in Wolfe Research Healthcare Conference
-
agilon health Reports Third Quarter 2021 Results
-
agilon health to Participate in the Credit Suisse 30th Annual Virtual Healthcare Conference
-
agilon health Sets Date to Report Third Quarter 2021 Financial Results
-
agilon health Names Mat Vargehese as New Chief People Officer
-
Zanesville Physician Recognized for Excellence in Senior Patient Care Honored During National Primary Care Week
-
Pittsburgh Physician Recognized for Excellence in Senior Care Honored During National Primary Care Week
-
PriMED Physicians Recognized for Excellence in Senior Patient Care Honored During National Primary Care Week Oct. 4-8
-
Buffalo Medical Group Physician Recognized for Excellence in Patient Care Honored During National Primary Care Week
-
Austin Physicians Recognized for Excellence in Senior Patient Care Honored During National Primary Care Week, Oct. 4-8
-
Angle PLC: Barts Research Supports Potential Use of Parsortix

